Human Drug Metabolism (eBook)
360 Seiten
John Wiley & Sons (Verlag)
978-0-470-68934-9 (ISBN)
provides an accessible introduction to the subject and will be
particularly invaluable to those who already have some
understanding of the life sciences. Completely revised and updated
throughout, the new edition focuses only on essential chemical
detail and includes patient case histories to illustrate the
clinical consequences of changes in drug metabolism and its impact
on patient welfare.
After underlining the relationship between efficacy, toxicity
and drug concentration, the book then considers how metabolizing
systems operate and how they impact upon drug concentration, both
under drug pressure and during inhibition. Factors affecting drug
metabolism, such as genetic polymorphisms, age and diet are
discussed and how metabolism can lead to toxicity is explained. The
book concludes with the role of drug metabolism in the commercial
development of therapeutic agents as well as the pharmacology of
some illicit drugs.
Dr Michael D. Coleman, Presently senior lecturer in toxicology at Aston University. During his career, Dr. Coleman has worked at Liverpool University, Walter Reed Army Institute of Research in Washington D.C. and latterly Aston University. His substantial and original contribution to knowledge of the biochemical pharmacology and toxicology of antiparasitic drugs has been acknowledged in the award of the degree of Doctor of Science from Aston University in 2005.
Preface.
Preface to First Edition.
1. Introduction.
1.1 Therapeutic window.
1.2 Consequences of drug concentration changes.
1.3 Clearance.
1.4 Hepatic extraction and intrinsic clearance.
1.5 First pass and plasma drug levels.
1.6 Drug and xenobiotic metabolism.
2. Drug Biotransformational Systems - Origins and Aims.
2.1 Biotransforming enzymes.
2.2 Threat of lipophilic hydrocarbons.
2.3 Cell communication.
2.4 Potential food toxins.
2.5 Sites of biotransforming enzymes.
2.6 Biotransformation and xenobiotic cell entry.
3. How Oxidative Systems Metabolize Substrates.
3.1 Introduction.
3.2 Capture of lipophilic molecules.
3.3 Cytochrome P450s classification and basic structure.
3.4 CYPs - main and associated structures.
3.5 Human CYP families and their regulation.
3.6 Main human CYP families.
3.7 Cytochrome P450 catalytic cycle.
3.8 Flavin monooxygenases (FMOs).
3.9 How CYP isoforms operate in vivo.
3.10 Aromatic ring hydroxylation.
3.11 Alkyl oxidations.
3.12 'Rearrangement' reactions.
3.13 Other oxidation processes.
3.14 Control of CYP metabolic function.
4. Induction of Cytochrome P450 Systems.
4.1 Introduction.
4.2 Causes of accelerated clearance.
4.3 Enzyme induction.
4.4 Mechanisms of enzyme induction.
4.5 Induction - general clinical aspects.
5. Cytochome P450 Inhibition.
5.1 Introduction.
5.2 Inhibition of metabolism - general aspects.
5.3 Mechanisms of inhibition.
5.4 Cell transport systems and inhibition.
5.5 Major clinical consequences of inhibition of drug clearance.
5.6 Use of inhibitors for positive clinical intervention.
5.7 Summary.
6. Conjugation and Transport Processes.
6.1 Introduction.
6.2 Glucuronidation.
6.3 Sulphonation.
6.4 The GSH system.
6.5 Glutahione S-transferases.
6.6 Epoxide hydrolases.
6.7 Acetylation.
6.8 Methylation.
6.9 Esterases/amidases.
6.10 Amino acid conjugation (glycine or glutamate).
6.11 Phase III transport processes.
6.12 Biotransformation-integration of processes.
7. Factors Affecting Drug Metabolism.
7.1 Introduction.
7.2 Genetic polymorphisms.
7.3 Effects of age on drug metabolism.
7.4 Effects of diet on drug metabolism.
7.5 Gender effects.
7.6 Smoking.
7.7 Effects of ethanol on drug metabolism.
7.8 Artificial livers.
7.9 Effects of diseases on drug metabolism.
9.10 Summary.
8. Role of Metabolism in Drug Toxicity.
8.1 Adverse drug reactions: definitions.
8.2 Reversible drug adverse effects: Type A.
8.3 Irreversible drug toxicity: Type B.
8.4 Type B1 necrotic reactions.
8.5 Type B2 reactions: immunotoxicity.
8.6 Type B3 reactions: role of metabolism in cancer.
8.7 Summary of biotransformational toxicity.
Appendix A: Methods in Drug Metabolism.
A.1 Introduction.
A.2 Analytical techniques.
A.3 Human liver microsomes.
A.4 Human hepatocytes.
A.5 Human cell lines.
A.6 Heterologous recombinant systems.
A.7 Animal model developments in drug metabolism.
A.8 Toxicological metabolism-based assays.
A.9 In silico studies.
A.10 Summary.
Appendix B. Metabolism of Major Illicit Drugs.
B.1 Introduction.
B.2 Opiates.
B.3 Cocaine.
B.4 Hallucinogens.
B.5 Amphetamines.
B.6 Cannabis.
B.7 Dissociative anaesthetics.
Appendix C. Examination Techniques.
C.1 Introduction.
C.2 A first-class answer.
C.3 Preparation.
C.4 The day of reckoning.
Appendix D. Summary of Major CYP Isoforms and their Substates, Inhibitors and Inducers.
Suggested Further Reading.
Index.
Reviews of first edition:
"The author has certainly achieved his goal of providing an
accessible introduction to human drug metabolism" (The Annals of
Pharmacotherapy, June 2006)
"Armed with the knowledge contained in this book, we should all
be well on the way" (Pharmaceutical Physician, May 2006)
"...a useful introductory text for the intended audience of
students studying pharmacology and toxicology..."
(Veterinary Pathology, November 2006)
| Erscheint lt. Verlag | 30.3.2010 |
|---|---|
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| Studium ► 2. Studienabschnitt (Klinik) ► Humangenetik | |
| Naturwissenschaften ► Biologie ► Mikrobiologie / Immunologie | |
| Technik | |
| Schlagworte | Biochemie • biochemistry • Biowissenschaften • Cell & Molecular Biology • Chemie • Chemistry • Genetik • Life Sciences • Molecular Pharmacology • Molekulare Pharmakologie • Zellbiologie • Zell- u. Molekularbiologie |
| ISBN-10 | 0-470-68934-X / 047068934X |
| ISBN-13 | 978-0-470-68934-9 / 9780470689349 |
| Haben Sie eine Frage zum Produkt? |
PDF (Adobe DRM)Größe: 3,9 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
